- Navigating Regulatory Requirements for Aseptic Processing and ATMPs
- The Evolution of Aseptic Technologies and Process Optimization
- Cleanrooms for Annex 1 Updates: Implementation Challenges and Best Practices
- Advancements in Vector Design and Development for Safe and Efficient Gene Therapies
- Strategies for Reducing Timelines in Cell and Gene Therapy Development
- Novel Approaches to Qualifying Materials in Aseptic and CGT Processing
Why should you attend?
The premier event for top executives on Aspetic Processing | Gene & Cell Therapies
Key Learning Points
- Robotic Applications in Aseptic Processing: Current Status and Future Trends
- Innovative Approaches in Quality Risk Management for Aseptic Processes
- Overcoming Technical Challenges in Decontamination and Filtration Processes
- Single-Use Systems Implementation in Aseptic Environments
- Strategic CMC Development for Aseptic Processing in ATMPs
- Occupational Safety and Environmental Monitoring in Aseptic Facilities
Who should attend?
Members of board, C-level, Senior Vice Presidents, Vice Presidents, Directors and Heads of departments from pharmaceutical/biotechnology industry / industries involved in:
- Adenovirus
- Advanced Therapy Medicinal Product
- Analytics
- Bioprocess Research
- Bioprocessing
- Biotechnology
- Biotherapeutics
- Cell Engineering
- Cell Therapy
- Cell-Based Medicinal Products
- Cellular Immunotherapy
- Cellular Therapy
- CMC
- CAR-T
- Clinical Development
- Commercialisation
- Comparability
- Compliance
- Container Development
- Drug Development
- Engineering
- Fill and Finish
- Formulation
- Freeze-Drying
- Gene Therapy
- GMP
- Immuno-Oncology
- Immunology
- Immunotherapy
- Lentivirus
- Licensing
- Lyophilisation
- Manufacturing
- Market Access
- Medical Affairs
- Medical Devices
- Nanomaterials
- Non-Viral Vectors
- Oncology
- Packaging and Labelling
- Parenterals
- Pharmaceutical Process and Technology
- Process Analytics
- Process Development
- Process Monitoring and Control
- Product Characterisation
- Product Innovation
- Production Engineering
- QA/QC
- Quality Assurance
- Quality Control
- R&D
- Regenerative Medicine
- Regulatory Affairs
- Research and Development
- Risk Management
- Safety
- Scale Up
- Stability
- Standardisation Science
- Stem Cell
- Sterilization
- Supply Chain
- Vaccine/Antibody/Cell Manufacturing
- Validation
- Viral Vector
What can you expect?
➜ 100+ industry delegates
➜ 60%+ C-suite executives & SP-VP
➜ 10+ Exhibitors & Sponsors
➜ Experts on APT | GCT | CMC | Bioprocessing and many more…
➜ 5+ hours of networking events
➜ Exclusive innovative data
➜ Delegates contact information
Our Clients
Several major clients have trusted on us making BPS one of the best conferences for executives in the World.
Early bird Registration is now open!
Register now before price goes up!
GENAP Summit is a brand owned by EPM Group, registered company in Portugal. EU VAT ID PT513501312